Fact Meets Function

This human clinical study examined how nicotinamide mononucleotide (NMN) supplementation affected inflammatory markers in skeletal muscle following blood flow restriction (BFR) exercise in humans. The researchers measured inflammatory responses in muscle tissue after participants completed BFR-exercise with and without NMN administration. The findings indicate that NMN supplementation was associated with reduced inflammatory markers in human skeletal muscle post-BFR exercise, though the magnitude and functional significance of these anti-inflammatory effects would require review of the full results.

This post hoc analysis of a randomized, double-blinded, placebo-controlled human clinical trial examined the relationship between blood NAD+ levels and various laboratory parameters in middle-aged healthy individuals, both at baseline and following nicotinamide mononucleotide (NMN) supplementation. The study identified associations between NAD+ levels and specific blood biomarkers, with changes occurring after NMN supplementation in this population. **Evidence level: Human clinical trial**

This human clinical study examined how nicotinamide mononucleotide (NMN) affects gene expression and biological responses in skin fibroblasts, with the goal of understanding potential longevity-related effects on skin. The researchers identified distinctive gene expression profiles in fibroblasts exposed to NMN and characterized the resulting biological responses that may be relevant to skin aging processes. This is human clinical-level evidence investigating NMN’s direct molecular effects on skin cells involved in collagen and structural protein production.

This study compared the effects of beta-hydroxybutyrate and NMN supplementation against caloric restriction in *Daphnia* (aquatic organisms), finding that beta-hydroxybutyrate supplementation replicated caloric restriction’s effect on reducing early mortality, while NMN supplementation did not produce similar benefits (animal model). The research suggests differential efficacy between these two proposed longevity interventions in this model organism, though findings in *Daphnia* may not directly translate to human physiology (animal model evidence level).